Hongxia Zhang

Director - Oncology Translational Asset Lead Translational Development @Bristol Myers Squibb

Philadelphia, PA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Nov 2025 — Present

Director - Oncology Translational Asset Lead Translational Development @Bristol Myers Squibb

View department →

NJ, US

EDUCATION

N/A

Thomas Jefferson University

Postdoctoral, Immunology and Microbiology

N/A

Nanjing University

Ph.D., Biochemistry and Molecular Biology

ABOUT HONGXIA ZHANG

Experienced, driven translational science lead, thriving to convert innovation to transformative medicine. Leader with agility, high sense of urgency, personal initiative, and a track record of success. Wide range of drug R&D experience spanning early discovery, translational research (forward/reverse), and clinical development (early/late). Expert knowledge in Oncology and Immunology across multiple treatment modalities (ICB, bispecific, ADC, cancer vaccine, targeted, and cell therapy). Skilled in building highly effective & aligned teams. Strong communication and influence management capabilities.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Hongxia Zhang — Director - Oncology Translational Asset Lead Translational Development at Bristol Myers Squibb in Philadelphia, PA, US | Unifers